ISSN: 1573-4080

Journal Home

Journal Guideline

Current Enzyme Inhibition Q4 Unclaimed

Bentham Science Publishers B.V. United Arab Emirates

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Current Enzyme Inhibition is a journal indexed in SJR in Biochemistry and Drug Discovery with an H index of 18. It has an SJR impact factor of 0,174 and it has a best quartile of Q4. It has an SJR impact factor of 0,174.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biochemistry (Q4) Drug Discovery (Q4) Molecular Medicine (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,174

SJR Impact factor

18

H Index

22

Total Docs (Last Year)

69

Total Docs (3 years)

1028

Total Refs

46

Total Cites (3 years)

61

Citable Docs (3 years)

0.71

Cites/Doc (2 years)

46.73

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cellular and Molecular Biology Q4
Journal of Lipids Q4
International Journal of Proteomics Q4
Journal of Carbohydrate Chemistry Q4
Journal of Cellular Neuroscience and Oxidative Stress Q4

Compare this journals

Aims and Scope

Best articles by citations

Cholinesterases and Cholinesterase Inhibitors

QSAR, Docking and Molecular Fragment Replacement Study based on a Conformation- Independent Approach on Trifluorophenyl beta-aminoamide derivatives as DPP IV Inhibitors

JAK Family of Tyrosine Kinases: Its Functions and Alterations in Human Cancer

The NPC1L1 Inhibitor Ezetimibe in the Treatment of the Dyslipidemia in Patients Affected by the Metabolic Syndrome: Evidences and Perspectives

Cytoprotective and Antiproliferative Effects of HMG-CoA Reductase Inhibitors

Aspartic Proteases of Human Pathogenic Fungi are Prospective Targets for the Generation of Novel and Effective Antifungal Inhibitors

Inhibiting Glutathione Metabolism in Lung Lining Fluid as a Strategy to Augment Antioxidant Defense

Highly Selective MEK Inhibitors

Fixed Dose Combination of Ceftazidime Plus Tobramycin Acts as Free Radical Scavenger in Liver of Mus musculus Mice

Paraoxonase-1 (PON1) as a Predictor of Biochemical Outcomes in Farmers

Screening of Two Algerian Spontaneous Plants for Anti-lipase and Antioxidant Activities

Caenorhabditis elegans: Study Model for Animal and Human Cathepsins and Inhibitors

SHOW MORE ARTICLES

Carbonic Anhydrase I and II Inhibition with Natural Products: Abrus precatorius

Controlling the Flow of Energy: Inhibition and Stimulation of the Creatine Transporter

Phospholipase D Inhibition: Beneficial and Harmful Consequences for a Double-Dealer Enzyme

Drug Target Discovery Through Analysis of Laccase Regulatory Networks of Cryptococccus neoformans

Clostridium difficile DNA Polymerase IIIC: Basis for Activity of Anti-Bacterial Compounds

Impaired Expression and Function of Signaling Pathway Enzymes by Anthocyanins: Role on Cancer Prevention and Progression

In-vitro Studies on alpha-Amylase, alpha-Glucosidase and Aldose Reductase Inhibitors found in Endophytic Fungi Isolated from Ocimum sanctum

Histone Deacetylase Inhibitors: Novel Immunomodulators

Kinetics and computational evaluation of eugenol and vanillic acid on inhibition of a potential enzyme of a nosocomial pathogen that promotes struvite formation

TGF-β : Titan of Lung Fibrogenesis

Acknowledgements to Reviewers:

Glucose Transporters in Normal and Diabetic Kidneys